This inventor holds 52 USPTO granted patents, plus 2 CIPO patents, primarily in Kappa Agonist Compounds (CPC class 5142). Top assignees: Adolor Corporation, Sterling Winthrop Inc., Sterling Drug Inc.. Active years: 1989-2011.
Inventors with similar research interests:
Location History:
- Colonie Township, Albany County, NY (US) (1992)
- Albany, NY (US) (1994)
- Tredyffrin Township, Chester County, PA (US) (1995 - 1997)
- Tredyffrin Township, PA (US) (1997)
- Colonie, NY (US) (1989 - 1999)
- Paoli, PA (US) (1996 - 2007)
- Berwyn, PA (US) (2004 - 2011)
Company Filing History:
26 out of 69Â 
14 out of 206Â 
4 out of 692Â 
Years Active: 1989-2011
Areas of Expertise:
Title: Innovations and Contributions of Virendra Kumar in the Pharmaceutical Field
Introduction: Virendra Kumar, based in Paoli, PA, is an accomplished inventor with an impressive portfolio of 52 patents. His work primarily focuses on the development of pharmaceutical formulations and methods that enhance drug efficacy, particularly in pain management and opioid-related treatments.
Latest Patents: Among his notable recent patents, Virendra has developed solid dispersions of opioid antagonists, specifically designed for improved water solubility and bioavailability. These formulations aim to address various opioid-related side effects and have significant implications for pain management, ileus, and opioid bowel dysfunction. Additionally, he has patented compounds with kappa opioid agonist activity, which can be utilized as analgesics and pruritic agents, showcasing his commitment to advancing therapeutic options in pain relief.
Career Highlights: Throughout his career, Virendra Kumar has contributed significantly to pharmaceutical innovation. He has worked with reputable organizations, including Adolor Corporation and Sterling Winthrop Inc., where he applied his expertise to develop cutting-edge solutions in drug formulation and delivery.
Collaborations: Virendra has collaborated with notable coworkers such as Wei Yuan Zhang and Alan L. Maycock, further enhancing the breadth of his contributions to the field. These partnerships have fostered an environment of innovation, driving forward the development of new pharmaceutical applications.
Conclusion: Virendra Kumar's extensive work and inventive spirit illustrate the vital role that innovation plays in the pharmaceutical industry. His patents not only reflect his personal achievements but also contribute to broader advancements in drug therapies, particularly in addressing the complex challenges surrounding opioid use.